Brain extracellular quinolinic acid in chronic experimental hepatic encephalopathy as assessed by in vivo microdialysis: Acute effects of L-tryptophan

Neuropsychopharmacology

Volumn 15, Issue 4, 1996, Pages 382-389

  Bergqvist, Peter B F ^a   Heyes, Melvyn P ^b   Apelqvist, Gustav ^a   Butterworth, Roger F ^c   Bengtsson, Finn ^a,d  

^a LUND UNIVERSITY   (Sweden)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF MONTREAL   (Canada)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hepatic encephalopathy; In vivo cerebral microdialysis; Kynurenines; Liver disease; Portacaval anastomosis; Quinolinic acid

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; QUINOLINIC ACID; TRYPTOPHAN;

ANIMAL EXPERIMENT; ARTICLE; EXTRACELLULAR FLUID; HEPATIC ENCEPHALOPATHY; INTRAPERITONEAL DRUG ADMINISTRATION; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030272835     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00256-D     Document Type: Article

References (39)

1. Baldessarini RJ, Fischer JE (1979): Serotonin metabolism in rat brain after surgical diversion of the portal venous circulation. Nature New Biol 245:25-27
2. Basile AS, Saito K, Al-Mardini H, Record CO, Hughes RD, Harrison P, Williams R, Li Y, Heyes MP (1995a): The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. Gastroenterology 108:818-823
3. Basile AS, Saito K, Li Y, Heyes MP (1995b): The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure. J Neurochem 64:2607-2614
4. Bengtsson F (1992): Neurotransmission failure in hepatic encephalopathy involving the combined action of different brain tryptophan-related pathology: A speculative synthesis. In Ishiguro I, Nagatsu T, Nagamura Y (eds), Advances in Tryptophan Research 1992. Toyoake, Japan, Fujita Health University Press, pp 303-308
5. Bengtsson F, Bugge M, Johansen KH, Butterworth RF (1991): Brain tryptophan hydroxylation in the portacaval shunted rat: A hypothesis for the regulation of serotonin turnover in vivo. J Neurochem 56:1069-1074
6. Bergeron M, Pomier Layrargues G, Butterworth RF (1989): Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Metab Brain Dis 4:169-176
7. Bergqvist PBF, Heyes MP, Bugge M, Bengtsson F (1995a): Brain quinolinic acid in chronic experimental hepatic encephalopathy: Effects of an exogenous ammonium acetate challenge. J Neurochem 65:2235-2240.
8. Bergqvist PBF, Vogels BAPM, Bosman DK, Maas MAW, Hjorth S, Chamuleau RAFM, Bengtsson F (1995b): Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt. J Neurochem 64:1238-1244
9. Butterworth RF (1992): Evidence that hepatic encephalopathy results from a defect of glutamatergic synaptic regulation. Mol Neuropharmacol 2:229-232
10. Carboni E, Di Chiara G (1989): Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience 32:637-645
11. Carboni E, Cadoni C, Tanda GL, Di Chiara G (1989): Calcium-dependent, tetrodotoxin-sensitive stimulation of cortical serotonin release after a tryptophan load. J Neurochem 53:976-978
12. Cascino A, Cangiano C, Fiaccadori F, Ghinelli F, Merli M, Pelosi G, Riggio O, Rossi-Fanelli F, Sacchini D, Stortoni M, Capocaccia L (1982): Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy. Dig Dis Sci 27:828-832
13. Crandall EA, Fernstrom JD (1983): Effect of experimental diabetes on the levels of aromatic and branched-chain amino acids in rat blood and brain. Diabetes 32:222-230
14. Cummings MG, Soeters PB, James JH, Keane JM, Fischer JE (1976): Regional brain indoleamine metabolism following chronic portacaval anastomosis in the rat. J Neurochem 27:501-509
15. Curzon G, Kantamaneni BD, Fernando JC (1975): Effects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J Neurochem 24: 1065-1070
16. During MJ, Freese A, Heyes MP, Swartz KJ, Markey SP, Roth RH, Martin JB (1989a): Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading. FEBS Lett 247:438-444
17. During MJ, Heyes MP, Freese A, Markey SP, Martin JB, Roth RH (1989b): Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loading. Brain Res 476:384-387
18. 18O)quinolinic acid: Its esterification without back exchange for use as internal standard in the quantification of brain and CSF quinolinic acid. Biomed Environ Mass Spectrom 15:291-293
19. Heyes MP, Markey SP (1988b): Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: Effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations. Anal Biochem 174:349-359
20. Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH (1993): A mechanism of quinolinic acid formation by brain in inflammatory neurologic disease: Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116:1425-1450
21. 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. J Pharmacol Exp Ther 265:707-712
22. Hutson DG, Ono J, Dombro RS, Levi JU, Livingstone A, Zeppa R (1979): A longitudinal study of tryptophan involvement in hepatic coma. Am J Surg 137:235-239
23. Hutson PH, Sarna GS, Kantamaneni BD, Curzon G (1985): Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis. J Neurochem 44:1266-1273
24. Jellinger K, Riederer P, Rausch WD, Kothbauer P (1978): Brain monoamines in hepatic encephalopathy and other types of metabolic coma. J Neural Transm 14:103-120
25. Kalen P, Kokaia M, Lindvall O, Björklund A (1988): Basic characteristics of noradrenaline release in the hippocampus of intact and 6-hydroxydopamine-lesioned rats as studied by in vivo microdialysis. Brain Res 474:374-379
26. Kitt TM, Spector R (1987): Transport of quinolinic acid into rabbit and rat brain. Neurochem Res 12:625-628
27. Mans AM, Biebuyck JF, Shelly K, Hawkins RA (1982): Regional blood-brain barrier permeability to amino acids after portacaval anastomosis. J Neurochem 38: 705-717
28. Mans AM, DeJoseph MR, Davis DW, Viña JR, Hawkins RA (1990): Early establishment of cerebral dysfunction after portacaval shunting. Am J Physiol 259:E104-E110
29. Moroni F, Lombardi G, Carlà V, Moneti G (1984): The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain. Brain Res 295:352-355
30. Moroni F, Lombardi G, Carlà V, Lal S, Etienne P, Nair NPV (1986a): Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure. J Neurochem 47:1667-1671
31. Moroni F, Lombardi G, Carlà V, Pellegrini D, Carassale GL, Cortesini C (1986b): Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy. J Neurochem 46:869-874
32. Ono J, Hutson DG, Dombro RS, Levi JU, Livingstone A, Zeppa R (1978): Tryptophan and hepatic coma. Gastroenterology 74:196-200
33. Paxinos G, Watson C (1982): The Rat Brain in Stereotaxic Coordinates. Orlando, FL, Academic Press
34. Rössle M, Luft M, Herz R, Klein B, Lehmann M, Gerok W (1984): Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: Serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution. Klin Wochenschr 62: 867-875
35. Rössle M, Herz R, Klein B, Gerok W (1986): Tryptophan-Metabolisms bei Lebererkrankungen: Eine pharmakokinetische und enzymatische Untersuchung. Klin Wochenschr 64:590-594
36. Smith AR, Rossi-Fanelli F, Ziparo V, James JH, Perelle BA, Fischer JE (1978): Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg 187:343-350
37. Speciale C, Okuno E, Schwartcz R (1987): Increased quinolinic acid metabolism following neuronal degeneration in the rat hippocampus. Brain Res 436:18-24
38. Stone TW (1993): Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45:309-379
39. Whetsell WO Jr, Schwarcz R (1989): Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett 97:271-275